Priyam Shah

Priyam Shah currently serves as the Head of Business Development, Corporate Strategy & Investor Relations at Akoya Biosciences, Inc., a position held since August 2021. Prior experience includes roles as a Life Science IPO & Strategy Advisor at Gilmartin Group LLC in 2021, a Healthcare Public Equity Investor at Reneo Capital LP from 2015 to 2020, a Healthcare Private Equity Associate at Apax in 2015, and a Life Science Venture Capital Associate at ATP Life Science Ventures in 2014. Priyam Shah holds an MBA from Columbia Business School, is an MD Candidate at Duke University School of Medicine, and earned a B.Sc. in Chemistry from Penn State University.